Porzio, Bromberg & Newman, P.C.
September 10-11, 2007
Marriott Georgetown University Conference Center, Washington, DC
CBI’s Forum on Tracking State Laws and Aggregate Spend
John Patrick Oroho, Executive Vice President, and Garineh Dovletian, Director of Quality Control, Porzio Pharmaceutical Services, will speak at CBI’s Forum on Tracking State Laws and Aggregate Spend on September 10, 2007 in Washington, DC.
Their presentation, entitled “State Legislation and Enforcement Initiatives,” will discuss the latest on state marketing disclosure laws and enforcement. A growing number of state legislatures are enacting laws, and each has a unique take on various marketing, advertising and sales activities within the industry. Difficulties lie in the number of varying requirements that are specific to each state, as well as the language in which laws are written that makes it hard to decipher what information companies need to report. In this session, the updates on state marketing disclosure laws, specifically those dealing with aggregating physician spend will be presented.
For additional information on this event, please select the following link:
http://www.cbinet.com/sho w_conference.cfm?confCode=PC07056&field=dayone
September 17-18, 2007
Renaissance Philadelphia - Airport, Philadelphia, PA
CBI’s Second Annual Conference on Bio/Pharmaceutical Educational Grants
Scott S. Liebman, Director of Quality Control, Porzio Pharmaceutical Services, will speak at CBI’s Second Annual Conference on Bio/Pharmaceutical Educational Grants on September 18, 2007 in Philadelphia.
His presentation, entitled, “Why Establishing a Successful Grant Review Committee Is Critical to Your Business,” will focus on the handling of grant requests by several different departments within a bio/pharmaceutical company. With the SFC investigation into the process of grant funding and who reviews and handles the process, grant review committees will take on a whole new importance. Attendees will learn how review committees can be used to add value to the grant process. Additional topics to be discussed are:
• Overview and update of legal and industry standards regarding grants, including continuing medical education grants
• Effects of the Senate Finance Committee’s investigation into grants related to continuing medical education
• Recommendations on establishing effective policies and procedures to govern the grant review process
• Evaluation of risks and consequences associated with grants
• Practical solutions to minimize and weigh those risks
For additional information on this event, please select the following link:
http://www.cbinet.com/sho w_conference.cfm?confCode=HB769
October 17, 2007
Auditorium Hotel, Madrid, Spain
DIA Workshop on Leveraging Knowledge Management
Linda Pissott Reig, Vice President, Compliance Services, Porzio Pharmaceutical Services, will speak at the Drug Information Association’s (DIA) Conference on Leveraging Knowledge Management, a Focus on Product Cross-Licensing, Product Liability & Pharmacovigilance on October 17, 2007 in Madrid, Spain.
Her presentation, entitled, “Only ‘Foolish’ Consistency is the Hobgoblin of Little Minds – Minimizing Product Liability Risk through Consistent Capture, Consideration and Communication of Postmarketing Adverse Events," will focus on balancing the tension between the traditional legal reasons for protecting information versus the business need to share Clinical, Regulatory and Pharmacovigilance information. Ms. Reig will also serve as the Session Chairperson for the topic, “Managing Product Liability Risk: The Knowledge Management & Legal Perspective.”
For additional information on this event, please select the following link:
http://www.diahome.org/DI AHome/Education/FindEducationalOffering.aspx?productID=14163&eventType=Meeting
October 24-26, 2007
Sheraton Philadelphia City Center Hotel, Philadelphia, PA
ACI’s Fraud and Abuse in the Sales & Marketing of Drugs
John Patrick Oroho, Executive Vice President, Porzio Pharmaceutical Services, will serve on a panel for a master class at ACI’s Fraud and Abuse in the Sales & Marketing of Drugs conference on October 26, 2007 in Philadelphia.
The master class, entitled “Fostering a Living Culture of Compliance,” will provide the perspectives of counsel and experts about compliance issues on the establishment of an effective compliance program and, more broadly, achieving a culture of compliance within a company. This "hands-on" session will work through hypothetical scenarios that address real-life situations, including:
• Prioritizing the concerns of the pharma company’s Chief Compliance Officer
• Compliance program metrics: how to define and measure effectiveness
• Effective top-down legal and ethical training
• Ensuring efficacy in internal investigations
• Compliance checks and balances
• Practical quality control and documentation strategies that show the company’s commitment to compliance
• Learning from Corporate Integrity Agreements
• Tips and techniques for tracking, developing and monitoring compliance programs taking into account divergent state laws
For additional information on this event, please select the following link:
http://www.americanconfer ence.com/Pharmaceuticals_Biotech_Life_Sciences/fadrugs.htm
October 25-26, 2007
Washington, DC
CBI’s Ninth Annual Conference on Guidelines for Disseminating Off-Label Information
Scott S. Liebman, Director of Quality Control, Porzio Pharmaceutical Services, will serve as a panelist at CBI’s Ninth Annual Conference on Guidelines for Disseminating Off-Label Information on October 25, 2007 in Washington, DC.
The panel discussion, entitled “How Criminal and Civil Enforcement is Shaping the Outlook for Off-Label Dissemination,” will focus on the current status of off-label enforcement efforts and analyze the significant off-label criminal and civil cases that have been resolved to understand the factors driving criminal and civil enforcement. This panel discusses lessons learned and offers insight into the current enforcement landscape for off-label dissemination. Additional topics to be discussed are:
• Overview of driving factors in federal enforcement efforts
• Role of corporate compliance programs
• Role of the whistleblower
• Consequences of sweeping CIAs
• Related civil suits
• Top executives’ individual liability
For additional information on this event, please select the following link:
http://www.cbinet.com/sho w_conference.cfm?confCode=PC07070&field=summary
November 8-9, 2007
Sheraton University City, Philadelphia, PA
ExL Pharma’s 3rd Annual Pharmaceutical Sampling Strategies Conference
John Patrick Oroho, Executive Vice President, Porzio Pharmaceutical Services, will speak at ExL Pharma’s 3rd Annual Pharmaceutical Sampling Strategies Conference on November 9, 2007 in Philadelphia.
His presentation, entitled “Protect Your Sampling Strategy: Enhancing Sales And Marketing Initiatives By Increasing Sample Compliance,” will give an independent review of OIG in terms of requirement expectations, analyze case studies where OIG, PDMA and state regulations actually conflict or contradict each other, and identify the dilemmas facing today’s industry with concrete models, processes and systems. It will also discuss innovative approaches to transform compliance dilemmas into competitive advantages, and how to experience significant cost reductions and enhance product promotion while actually increasing compliance and insulating from liability.
For additional information on this event, please select the following link:
http://www.exlpharma.com/ eventDetail.php?id=82
|  |
StayinFront, Inc.
September 11-12, 2007
Singapore
Sales Force Effectiveness Asia-Pacific Conference for pharma
Eyeforpharma Sales Force Effectiveness Summit Asia-Pacific is an in-depth exploration of the latest strategies, tools and best practice to increase the efficiency and effectiveness of your sales force. A few topics being covered at this show include:
• Effective techniques for measuring the effectiveness of your sales force
• Practical insights for integrating sales and marketing for optimising promotional spend
• How to integrate data sources for 360 degree of your customers
• Optimising data analysis for a truly customer-centric approach
For additional information on this event, please select the following link:
http://www.eyeforpharma.c om/sfeapac/
October 14-17, 2007
Chicago, IL
The 2007 PDMA Sharing Conference
This year’s expanded program will feature workshops that deal with the foundations of compliance, focused on specifically selected topics to challenge and motivate PDMA compliance professionals. The conference will offer learning opportunities that meet the needs of all attendees: from basic PDMA instruction for newcomers to in-depth discussions focused on the issues that challenge even the most seasoned compliance professionals.
Visit StayinFront, Inc. for product demonstrations.
For additional information on this event, please select the following link:
http://www.pdmaalliance.o rg/about_conf.html
October 25-27, 2007
Barcelo Sants, Barcelona
Pharma Marketing ROI: 7th Annual European Pharmaceutical Congress 6th Annual Marketing ROI Congress
This 7th annual eyeforpharma Congress will bring together another top selection of Pharma specialists and experienced professionals to share their knowledge and their views and present on the hottest topics around ROI and Marketing Excellence.
Just a few of the topics being discussed in depth include:
• Get the right CRM and segmentation strategy in place to improve efficiency, increase early market penetration and reduce costs
• Achieve a successful customer-centric, relationship marketing model to win repeat custom and protect market share
• Learn how to calculate ROI for both promotional and educational campaigns
• Discover leading strategies for launching and managing niche products in a rapidly specialising world
Visit StayinFront for product demonstrations.
For additional information on this event, please select the following link:
http://www.eyeforpharma.c om/marketing07/
|
